U.S. federal trademark · Serial No. 88106887
An implantable drug delivery matrix for intraoperative delivery of sirolimus to the vascular wall, the formulation consisting of a collagen membrane incorporating an active pharmaceutical ingredient, namely, sirolimus, for improving functional outcomes of procedures that involve the creation of a vascular anastomosis administered by physicians during surgery
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.